Shonukan, O., Dantzig, A., Kloeker-Rhoades, S., & Garcia-Ribas, I. (2009). Development of LY2334737, an oral gemcitabine prodrug for continuous administration. Perspectives for the therapy of mature T-cell and NK-cell lymphomas. Hematology Meeting Reports (formerly Haematologica Reports), 3(1). https://doi.org/10.4081/hmr.v3i1.533